MyFinsight
Home
Blog
About
Contact
Download
Download image
Net gain
-$3,775,804
(-7.71%↓ Y/Y)
Loss before
provision for income taxes
-$3,775,804
Foreign exchange gain
(loss)
$30,652
(32.64%↑ Y/Y)
Loss from operations
-$3,806,456
(-7.87%↓ Y/Y)
Total operating
expenses
$3,806,456
(7.87%↑ Y/Y)
Research and development
$2,425,551
(40.45%↑ Y/Y)
General and
administrative
$1,380,905
(-23.35%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Sonnet BioTherapeutics Holdings, Inc. (SONN)